Insider trades
Jason R. Kelly, Officer of Ginkgo Bioworks Holdings DNA, has filed 0 purchases and 127 sales on the open market. Over the past 12 months that comes to a net sale of $1.4M. The latest trade was on 04/09.
Jason R. Kelly
SEE REMARKS
- Company
- Ginkgo Bioworks Holdings DNA
- First filing
- 23/01/10
- Trades
- 132 trades
- Buys / sales
- 0 / 127
- 12-month net buying
- −$1.4M
- Last trade
- 04/09
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
DNA | Open-market sale | 04/08–04/09 | 04/10 | 206,782 sh2 trades | $6.65avg. | $1,374,822.75 | −39.5% |
DNA | Open-market sale10b5-1 plan | 24/01/03–24/01/04 | 24/01/05 | 200,000 sh2 trades | $1.55avg. | $310,000 | −4.9% |
DNA | Open-market sale10b5-1 plan | 23/12/20–23/12/21 | 23/12/22 | 200,000 sh2 trades | $1.77avg. | $353,000 | −4.7% |
DNA | Open-market sale10b5-1 plan | 23/12/13–23/12/14 | 23/12/15 | 200,000 sh2 trades | $1.49avg. | $297,284.2 | −4.4% |
DNA | Open-market sale10b5-1 plan | 23/12/06–23/12/07 | 23/12/08 | 200,000 sh2 trades | $1.32avg. | $263,000 | −4.3% |
DNA | Open-market sale10b5-1 plan | 23/11/29–23/11/30 | 23/12/01 | 200,000 sh2 trades | $1.40avg. | $280,000 | −4.1% |
DNA | Open-market sale10b5-1 plan | 23/11/22–23/11/24 | 23/11/27 | 200,000 sh2 trades | $1.41avg. | $281,000 | −3.9% |
DNA | Open-market sale10b5-1 plan | 23/11/15–23/11/16 | 23/11/17 | 200,000 sh2 trades | $1.50avg. | $299,000 | −3.8% |
DNA | Open-market sale10b5-1 plan | 23/11/08–23/11/09 | 23/11/13 | 200,000 sh2 trades | $1.40avg. | $279,000 | −3.6% |
DNA | Open-market sale10b5-1 plan | 23/11/01–23/11/02 | 23/11/03 | 200,000 sh2 trades | $1.43avg. | $286,000 | −3.5% |
DNA | Open-market sale10b5-1 plan | 23/10/25–23/10/26 | 23/10/27 | 200,000 sh2 trades | $1.47avg. | $294,000 | −3.4% |
DNA | Open-market sale10b5-1 plan | 23/10/18–23/10/19 | 23/10/20 | 200,000 sh2 trades | $1.65avg. | $330,000 | −3.3% |
DNA | Open-market sale10b5-1 plan | 23/10/11–23/10/12 | 23/10/13 | 200,000 sh2 trades | $1.71avg. | $342,000 | −3.2% |
DNA | Open-market sale10b5-1 plan | 23/10/04–23/10/05 | 23/10/06 | 200,000 sh2 trades | $1.65avg. | $329,000 | −3.1% |
DNA | Open-market sale10b5-1 plan | 23/09/27–23/09/28 | 23/09/29 | 200,000 sh2 trades | $1.79avg. | $358,000 | −3.0% |
DNA | Open-market sale10b5-1 plan | 23/09/20–23/09/21 | 23/09/22 | 200,000 sh2 trades | $1.81avg. | $361,000 | −2.9% |
DNA | Open-market sale10b5-1 plan | 23/09/13–23/09/14 | 23/09/15 | 200,000 sh2 trades | $2.02avg. | $404,000 | −2.8% |
DNA | Open-market sale10b5-1 plan | 23/09/06–23/09/07 | 23/09/08 | 200,000 sh2 trades | $2.18avg. | $436,000 | −2.7% |
DNA | Open-market sale10b5-1 plan | 23/08/30–23/08/31 | 23/09/01 | 200,000 sh2 trades | $2.26avg. | $451,000 | −2.7% |
DNA | Open-market sale10b5-1 plan | 23/08/23–23/08/24 | 23/08/25 | 200,000 sh2 trades | $1.72avg. | $344,000 | −2.6% |